Neurogene Inc.

By person

15 insiders · 134 transactions

78.4×

Rachel McMinn holds 78.4 times base salary in stock. $48.58M of shares against $618.80K in salary for 2025.

Salary from the company's own proxy. The shares are what Rachel McMinn last reported holding, valued at $36.13, the price Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BAKER BROS. ADVISORS LP entity

Director

$75.34M (49)

—

+$75.34M

5,162,141

25.80%

$186.53M

−16.9%

DRACHMAN JONATHAN G

President and CEO

$3.19M (9)

—

+$3.19M

2,373,686

11.86%

$85.77M

+1,010%

Redmile Group, LLC entity

10% owner

$2.01M (9)

$220.15K (4)

+$1.79M

4,041,211

20.19%

$146.03M

+4.5%

Samsara BioCapital GP, LLC entity

10% owner

$1.26M (4)

—

+$1.26M

1,717,127

8.58%

$62.05M

+2.9%

McMinn Rachel

Chief Executive Officer

$969.00K (1)

$74.00K (1) scheduled

+$895.00K

1,344,307

6.72%

$48.58M

+7.5%

Cvijic Christine Mikail

President and CFO

$491.40K (1)

$976.27K (13) scheduled

−$484.87K

84,040

0.4200%

$3.04M

+301.3%

Walkey Carl

Senior Vice President

—

$425.64K (26)

−$425.64K

1,352,489

6.76%

$48.87M

−2.5%

Cobb Stuart

Chief Scientific Officer

—

$244.45K (4) scheduled

−$244.45K

30,497

0.1524%

$1.10M

—

Main David

President and CEO

—

$207.24K (3) scheduled

−$207.24K

71,530

0.3574%

$2.58M

0.0%

Ho Robert

Chief Financial Officer

—

$71.56K (1)

−$71.56K

21,503

0.1075%

$776.99K

+616.8%

LEVITT DANIEL J

Director

—

$49.49K (1) scheduled

−$49.49K

0.0000%

$0.00

—

MacKenzie Lloyd

Chief Operating Officer

—

$19.05K (1) scheduled

−$19.05K

0.0000%

$0.00

—

Jordan Julie

Chief Medical Officer

—

$18.13K (1) scheduled

−$18.13K

12,472

0.0623%

$450.66K

—

Patel Priti

Former Chief Medical Officer

—

$17.94K (3)

−$17.94K

37,313

0.1865%

$1.35M

+521.9%

Smith Sean Michael

Interim CFO, Prin Acct Off

—

$4.44K (3)

−$4.44K

21,637

0.1081%

$781.83K

+298.4%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Cvijic Christine Mikail

7 Jul 2026

President and CFO

Sold on a plan

4,200

$36.13

$151.76K

Cvijic Christine Mikail

6 Jul 2026

President and CFO

Sold on a plan

600

$36.02

$21.61K

Cvijic Christine Mikail

2 Jul 2026

President and CFO

Sold on a plan

1,530

$35.23

$53.90K

Cvijic Christine Mikail

2 Jul 2026

President and CFO

Sold on a plan

2,531

$34.58

$87.52K

Cvijic Christine Mikail

1 Jul 2026

President and CFO

Sold on a plan

739

$34.06

$25.17K

Cvijic Christine Mikail

6 May 2026

President and CFO

Sold on a plan

4,800

$32.44

$155.69K

Cvijic Christine Mikail

6 May 2026

President and CFO

Sold on a plan

4,800

$30.07

$144.35K

Jordan Julie

26 Mar 2026

Chief Medical Officer

Sold on a plan

828

$21.89

$18.13K

McMinn Rachel

26 Mar 2026

Chief Executive Officer

Sold on a plan

3,352

$22.07

$74.00K

Cvijic Christine Mikail

26 Mar 2026

President and CFO

Sold on a plan

2,558

$21.62

$55.32K

Cvijic Christine Mikail

13 Mar 2026

President and CFO

Sold on a plan

263

$22.02

$5.79K

Cvijic Christine Mikail

13 Mar 2026

President and CFO

Sold on a plan

1,395

$21.25

$29.64K

Cvijic Christine Mikail

13 Mar 2026

President and CFO

Sold on a plan

2,387

$20.42

$48.75K

Cobb Stuart

13 Mar 2026

Chief Scientific Officer

Sold on a plan

148

$22.08

$3.27K

Cobb Stuart

13 Mar 2026

Chief Scientific Officer

Sold on a plan

2,658

$21.34

$56.72K

Cobb Stuart

13 Mar 2026

Chief Scientific Officer

Sold on a plan

3,991

$20.41

$81.46K

Cvijic Christine Mikail

27 Feb 2026

President and CFO

Sold on a plan

4,800

$25.11

$120.53K

Cobb Stuart

14 May 2025

Chief Scientific Officer

Sold on a plan

6,797

$15.15

$103.00K

Cvijic Christine Mikail

13 Mar 2025

President and CFO

Sold on a plan

4,501

$16.94

$76.25K

Show all 134 transactions →

By person

Individual transactions

What was left out